Back to results
US 6,310,092 B1Granted
Methods for preventing and treating autoimmune and inflammatory disease using thioether furan nitrone compounds
AssigneeCentaur Pharmaceuticals, Inc.
InventorsJudith A. Kelleher, Kirk R. Maples, Yong-Kang Zhang
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for preventing the onset of autoimmune or inflammatory diseases in mammals using a pharmaceutical composition containing a pharmaceutically acceptable carrier and an effective amount of a thioether furan nitrone compound.
Claims16
A method for preventing the onset of an autoimmune or inflammatory disease in a patient at risk for developing an autoimmune or inflammatory disease which method comprises:
- (a) identifying a patient at risk for developing an autoimmune or inflammatory disease;
- (b) administering to said patient a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective autoimmune or inflammatory disease-preventing amount of a compound of formula I:
- wherein
- R1 is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cyloalkyl, cycloalkylalkyl and cycloalkenyl;
- each R2 is independently selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, alkoxy, substituted alkoxy, cycloalkyl and halo;
- R3 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cycloalkyl and cycloalkylalkyl;
- R4 is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, aralkyl, aryl, cycloalkyl, cycloalkylalkyl and cycloalkenyl;
- and
- n is an integer ranging from 0 to 2;
- and optical isomers and racemates thereof, and pharmaceutically acceptable salts thereof.
7 more elements
Dependencies are inferred from the claim text.